STOCK TITAN

MaxLinear (MXL) Financials

MXL NASDAQ
Trailing 12 months to September 30, 2026
Revenue $660.5M +56.0% YoY
Net Income -$29.4M n/m YoY
EPS (Diluted) -$0.37 n/m YoY
Free Cash Flow -$20.6M n/m YoY
Market Cap $4.4B as of Nov 19, 2026
Price / Sales 6.6x on $660.5M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book 8.2x on $533.0M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 22, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MXL SEC filings page.

MaxLinear, Inc. (MXL) reported $660.5M in revenue over the twelve months to Sep 30, 2026, up 56.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MXL FY2025

FY2025 sales recovered, but persistent operating costs kept MaxLinear loss-making despite gross-margin improvement and only modest positive cash flow.

FY2025 revenue rose 29.7% from FY2024 while gross margin expanded, yet the company still posted an operating loss of $126.9M. That gap reflects a heavy expense base: R&D was $208.6M and SG&A was $159.6M, leaving gross profit unable to absorb operating costs.

FY2025's net loss was $136.7M, yet operating cash flow was positive at $19.6M, so reported losses overstated the immediate cash drain. After $12.6M of capital spending, free cash flow was only $7.0M, showing that cash conversion remained weak even as it turned positive.

Debt remains modest relative to equity at 0.3x, but total assets fell 7.9% in FY2025 while liabilities changed little. The current ratio was 1.3x, below 2.2x in FY2023, indicating less short-term flexibility.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 55 / 100
Financial Health Score (5 of 6 dimensions) 55/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of MaxLinear, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
87

MaxLinear, Inc. held $72.8M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $19.6M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and MaxLinear, Inc. scores 87/100 among other emerging companies.

Dilution
74

Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. MaxLinear, Inc. scores 74/100 on it among other emerging companies.

R&D Intensity
67

MaxLinear, Inc. spent $208.6M on research and development in fiscal year 2025, which was 35.1% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and MaxLinear, Inc. scores 67/100 among other emerging companies.

Revenue Progress
21

Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. MaxLinear, Inc. scores 21/100 on it among other emerging companies.

Burn Trend
n/a

Not available for MaxLinear, Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Balance Sheet
28

MaxLinear, Inc.'s cash, cash equivalents and investments came to $72.8M at the end of fiscal year 2025, against $344.5M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and MaxLinear, Inc. scores 28/100 among other emerging companies.

Altman Z-Score Safe
6.90

MaxLinear, Inc. scores 6.90, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $4.4B against total liabilities of $344.5M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

MaxLinear, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Mixed
N/A

MaxLinear, Inc. reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

MaxLinear, Inc. reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$218.1M
YoY+72.4%
QoQ+29.1%
5Y CAGR-1.0%
10Y CAGR+8.5%

MaxLinear, Inc. generated $218.1M in revenue in Q3 2026. This represents an increase of 72.4% from the same quarter a year earlier. Against the prior quarter it is up 29.1%.

EBITDA
$39.1M
YoYn/m
QoQ+1200.1%
5Y CAGR-3.6%

MaxLinear, Inc.'s EBITDA was $39.1M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 1200.1%.

Net Income
$28.9M
YoYn/m
QoQ+1542.2%
5Y CAGR+25.6%
10Y CAGR+11.6%

MaxLinear, Inc. reported $28.9M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 1542.2%.

EPS (Diluted)
$0.30
YoYn/m
QoQ+1400.0%
5Y CAGR+20.1%
10Y CAGR+7.9%

MaxLinear, Inc. earned $0.30 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 1400.0%.

Cash & Balance Sheet

Free Cash Flow
-$19.5M
YoY-544.4%
QoQ-890.4%

MaxLinear, Inc. recorded an outflow of $19.5M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 544.4% from the same quarter a year earlier. Against the prior quarter it is down 890.4%.

Cash & Debt
$81.1M
YoY-27.5%
QoQ+25.1%
5Y CAGR-13.7%
10Y CAGR+3.8%

MaxLinear, Inc. held $81.1M in cash against $164.1M in long-term debt as of Q3 2026.

Shares Outstanding
91M
YoY+4.2%
QoQ+0.3%
5Y CAGR+3.5%
10Y CAGRn/m

MaxLinear, Inc. had 91M shares outstanding in Q3 2026. This represents an increase of 4.2% from the same quarter a year earlier. Against the prior quarter it is up 0.3%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
58.7%
YoY+1.9pp
QoQ+0.9pp
5Y change+2.2pp
10Y change+1.1pp

MaxLinear, Inc.'s gross margin was 58.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Operating Margin
13.9%
YoY+46.5pp
QoQ+16.3pp
5Y change+3.5pp

MaxLinear, Inc.'s operating margin was 13.9% in Q3 2026, reflecting core business profitability. This is up 46.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 16.3 percentage points.

Net Margin
13.3%
YoY+49.2pp
QoQ+12.2pp
5Y change+9.2pp
10Y change+3.2pp

MaxLinear, Inc.'s net profit margin was 13.3% in Q3 2026, showing the share of revenue converted to profit. This is up 49.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.2 percentage points.

Return on Equity
5.4%
YoY+15.2pp
QoQ+5.1pp
5Y change+3.4pp
10Y change+2.6pp

MaxLinear, Inc.'s quarterly ROE was 5.4% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 15.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.1 percentage points.

Capital Allocation

R&D Spending
$60.6M
YoY+11.8%
QoQ+8.2%
5Y CAGR-2.1%

MaxLinear, Inc. invested $60.6M in research and development in Q3 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is up 8.2%.

Capital Expenditures
$5.9M
YoY+3.7%
QoQ+154.1%
5Y CAGR-9.2%
10Y CAGR+10.9%

MaxLinear, Inc. invested $5.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 3.7% from the same quarter a year earlier. Against the prior quarter it is up 154.1%.

Share Buybacks

Not reported for Q3 2026.

MXL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MXL quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$218.1M+72.4%$168.8M+55.2%$137.2M+43.0%$136.4M+48.0%$126.5M+55.9%$108.8M+18.3%$95.9M+0.7%$92.2M-26.5%
Cost of Revenue$90.0M+64.9%$71.2M+50.5%$58.3M+38.5%$57.9M+41.4%$54.6M+47.4%$47.3M+13.1%$42.1M-8.5%$40.9M-28.0%
Gross Profit$128.1M+78.1%$97.7M+58.7%$78.9M+46.5%$78.6M+53.3%$71.9M+63.1%$61.5M+22.6%$53.8M+9.3%$51.2M-25.2%
R&D Expenses$60.6M+11.8%$56.0M+18.7%$53.2M-4.1%$51.7M+0.8%$54.3M+3.1%$47.2M-16.5%$55.5M-14.4%$51.3M-21.4%
SG&A Expenses$36.9M-22.5%$45.8M+37.1%$42.5M+16.0%$42.0M+10.2%$47.7M+58.1%$33.4M-0.7%$36.6M+0.3%$38.1M+10.8%
Operating Income$30.2Mn/m-$4.2Mn/m-$17.2Mn/m-$14.9Mn/m-$41.3Mn/m-$24.6Mn/m-$46.1Mn/m-$41.2Mn/m
EBITDA$39.1Mn/m$3.0Mn/m-$6.3Mn/m-$389Kn/m-$32.3Mn/m-$15.3Mn/m-$34.9Mn/m-$29.5Mn/m
Interest Expense$2.7M+1.6%$2.3M-9.7%$2.2M-12.3%$2.4M-14.7%$2.6M-0.2%$2.5M-7.2%$2.5M-7.6%$2.8M-3.7%
Income Tax-$732K-134.9%-$8.3Mn/m$26.5M+3625.0%-$2.9M-117.1%$2.1Mn/m-$4.1Mn/m$711Kn/m$17.0Mn/m
Net Income$28.9Mn/m$1.8Mn/m-$45.1Mn/m-$14.9Mn/m-$45.5Mn/m-$26.6Mn/m-$49.7Mn/m-$57.8Mn/m
EPS (Basic)$0.32n/m$0.02n/m-$0.52n/m-$0.17n/m-$0.52n/m-$0.31n/m-$0.58n/m-$0.68n/m
EPS (Diluted)$0.30n/m$0.02n/m-$0.52n/m-$0.17n/m-$0.52n/m-$0.31n/m-$0.58n/m-$0.68n/m
Diluted Shares (Avg)98M+12.1%97M+12.4%88M+2.7%N/A87M+3.7%87M+3.8%85M+3.5%N/A

MXL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MXL quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$916.4M+13.4%$822.6M-4.8%$771.3M-9.8%$796.4M-7.9%$808.1M-9.7%$863.7M-11.2%$855.3M-17.0%$864.6M-20.0%
Current Assets$391.2M+37.7%$298.7M-9.5%$249.4M-22.1%$248.8M-23.1%$284.1M-13.4%$330.1M-17.0%$320.4M-27.9%$323.4M-33.7%
Cash & Equivalents$81.1M-27.5%$64.8M-40.3%$61.1M-40.6%$72.8M-38.6%$111.9M-24.7%$108.6M-41.3%$102.8M-46.4%$118.6M-36.7%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$113.7M+31.7%$105.5M+22.6%$85.8M-0.2%$78.1M-13.5%$86.3M-10.1%$86.0M-9.2%$86.0M-10.5%$90.3M-9.6%
Accounts Receivable$73.4M+38.6%$51.0M-51.8%$40.9M-58.7%$46.1M-46.0%$52.9M+10.4%$105.8M+24.6%$98.9M-21.6%$85.5M-49.9%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$318.6M0.0%$318.6M0.0%$318.6M0.0%$318.6M0.0%$318.6M0.0%$318.6M0.0%$318.6M0.0%$318.6M0.0%
Total Liabilities$383.4M+11.7%$337.7M-10.0%$317.1M-12.4%$344.5M-1.1%$343.4M+1.5%$375.4M+5.5%$362.1M-7.8%$348.4M-11.6%
Current Liabilities$176.4M-3.9%$168.1M-21.3%$146.7M-25.5%$186.0M+2.0%$183.6M+8.9%$213.5M+12.2%$196.9M-12.0%$182.3M-17.9%
Non-Current Liabilities$207.0M+29.5%$169.6M+4.8%$170.4M+3.2%$158.5M-4.6%$159.9M-5.9%$161.9M-2.3%$165.2M-2.1%$166.1M-3.4%
Long-Term Debt$164.1M+32.9%$123.9M+0.5%$123.8M+0.5%$123.6M+0.5%$123.5M+0.5%$123.3M+0.5%$123.2M+0.5%$123.0M+0.5%
Total Equity$533.0M+14.7%$484.8M-0.7%$454.2M-7.9%$451.9M-12.5%$464.7M-16.5%$488.3M-20.9%$493.2M-22.7%$516.3M-24.8%
Retained Earnings-$514.9Mn/m-$543.8Mn/m-$545.5Mn/m-$500.4Mn/m-$485.5Mn/m-$440.0Mn/m-$413.4Mn/m-$363.7Mn/m

MXL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MXL quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$13.6M-234.2%$4.8M-54.2%-$8.9Mn/m$10.4Mn/m$10.1Mn/m$10.5Mn/m-$11.4M-171.4%-$27.8Mn/m
Depreciation & Amortization$8.9M-1.7%$7.2M-23.0%$10.9M-1.9%$16.4M+40.2%$9.0M-25.8%$9.3M-31.4%$11.1M-33.2%$11.7M-29.4%
Stock-Based Compensation$19.8M-7.8%$27.5M+109.6%$20.0M-12.6%N/A$21.5M+68.2%$13.1M-24.5%$22.9M+34.3%N/A
Capital Expenditures$5.9M+3.7%$2.3M+99.5%$1.4M-30.4%$3.7M+69.1%$5.7M+38.6%$1.2M-61.1%$2.0M-76.2%$2.2M+72.1%
Free Cash Flow-$19.5M-544.4%$2.5M-73.5%-$10.3Mn/m$6.7Mn/m$4.4Mn/m$9.3Mn/m-$13.4M-275.5%-$30.0Mn/m
Investing Cash Flow-$9.6Mn/m-$3.1Mn/m-$4.2Mn/m-$3.7Mn/m-$6.7Mn/m-$7.4Mn/m-$2.0Mn/m-$3.0M-120.2%
Financing Cash Flow$39.9M+265940.0%$1.6M-22.6%$2.3Mn/m-$18.6M-1409.9%$15Kn/m$2.1M+2.6%-$2.1Mn/m$1.4M+21.3%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MXL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MXL quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin58.7%+1.9pp57.8%+1.3pp57.5%+1.4pp57.6%+2.0pp56.9%+2.5pp56.5%+2.0pp56.1%+4.4pp55.6%+0.9pp
Operating Margin13.9%+46.5pp-2.5%+20.1pp-12.5%+35.5pp-10.9%+33.8pp-32.6%+49.6pp-22.6%+21.7pp-48.0%+30.3pp-44.7%-11.4pp
Net Margin13.3%+49.2pp1.0%+25.5pp-32.9%+18.9pp-10.9%+51.8pp-36.0%+57.5pp-24.4%+18.3pp-51.8%+24.1pp-62.7%-32.0pp
Return on Equity5.4%+15.2pp0.4%+5.8pp-9.9%+0.1pp-3.3%+7.9pp-9.8%+3.8pp-5.4%+0.9pp-10.1%+1.2pp-11.2%-5.6pp
Return on Assets3.1%+8.8pp0.2%+3.3pp-5.9%0.0pp-1.9%+4.8pp-5.6%+2.8pp-3.1%+1.0pp-5.8%+1.2pp-6.7%-3.1pp
Current Ratio2.22+0.7x1.78+0.2x1.70+0.1x1.34-0.4x1.55-0.4x1.55-0.5x1.63-0.4x1.77-0.4x
Debt-to-Equity0.310.0x0.260.0x0.270.0x0.270.0x0.270.0x0.25+0.1x0.25+0.1x0.24+0.1x
Liabilities-to-Equity0.720.0x0.70-0.1x0.700.0x0.76+0.1x0.74+0.1x0.77+0.2x0.73+0.1x0.67+0.1x
Asset Turnover0.24+0.1x0.21+0.1x0.18+0.1x0.17+0.1x0.16+0.1x0.130.0x0.110.0x0.110.0x
FCF Margin-9.0%-12.4pp1.5%-7.1pp-7.5%+6.5pp4.9%+37.5pp3.5%+46.5pp8.6%+14.8pp-14.0%-22.0pp-32.6%-18.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
MaxLinear, Inc. MXL FY2025 $467.6M -$136.7M -29.2% $4.4B 55/100
Silicon Motion Technology Corporation SIMO FY2025 $885.6M $122.6M 13.9% $4.9B 63/100
Impinj, Inc. PI FY2025 $361.1M -$10.8M -3.0% $4.9B 45/100
Synaptics Inc SYNA FY2026 $1.2B -$490.8M -41.0% $4.6B 36/100
Allegro MicroSystems, Inc. ALGM FY2026 $890.1M -$14.9M -1.7% $5.3B 49/100
Cirrus Logic Inc CRUS FY2026 $2.0B $414.4M 20.8% $5.7B 83/100

Frequently Asked Questions

MaxLinear, Inc. (MXL) reported $467.6M in total revenue for fiscal year 2025. This represents a 29.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

MaxLinear, Inc. (MXL) revenue grew by 29.7% year-over-year, from $360.5M to $467.6M in fiscal year 2025.

No, MaxLinear, Inc. (MXL) reported a net loss of $29.4M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $136.7M, with a net profit margin of -29.2%.

MaxLinear, Inc. (MXL) reported diluted earnings per share of -$1.58 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

MaxLinear, Inc. (MXL) had EBITDA of -$82.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, MaxLinear, Inc. (MXL) had $72.8M in cash and equivalents against $123.6M in long-term debt.

MaxLinear, Inc. (MXL) had a gross margin of 56.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

MaxLinear, Inc. (MXL) had an operating margin of -27.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

MaxLinear, Inc. (MXL) had a net profit margin of -29.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

MaxLinear, Inc. (MXL) has a return on equity of -30.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

MaxLinear, Inc. (MXL) generated $7.0M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

MaxLinear, Inc. (MXL) generated $19.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

MaxLinear, Inc. (MXL) had $796.4M in total assets as of fiscal year 2025, including both current and long-term assets.

MaxLinear, Inc. (MXL) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

MaxLinear, Inc. (MXL) invested $208.6M in research and development during fiscal year 2025.

Yes, MaxLinear, Inc. (MXL) spent $20.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

MaxLinear, Inc. (MXL) had 86M shares outstanding as of fiscal year 2025.

MaxLinear, Inc. (MXL) had a current ratio of 1.34 as of fiscal year 2025, which is considered adequate.

MaxLinear, Inc. (MXL) had a debt-to-equity ratio of 0.27 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

MaxLinear, Inc. (MXL) had a liabilities-to-equity ratio of 0.76 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

MaxLinear, Inc. (MXL) had a return on assets of -17.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

MaxLinear, Inc. (MXL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $4.4B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

MaxLinear, Inc. (MXL) trades at 6.6x sales, its market capitalization divided by $660.5M revenue, trailing 12 months to September 30, 2026. The market capitalization is $4.4B as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

MaxLinear, Inc. (MXL) has an Altman Z-Score of 6.90, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

MaxLinear, Inc. (MXL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

MaxLinear, Inc. (MXL) reported a net loss of $136.7M while generating $19.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

MaxLinear, Inc. (MXL) reported an operating loss of $126.9M against $10.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

MaxLinear, Inc. (MXL) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For MaxLinear, Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top